HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quan Liu Selected Research

valibose

8/2013[Valibose, an alpha-glucosidase inhibitor, ameliorates the metabolic disorder of glucose and lipids and the nephropathy in streptozotocin-induced diabetic rats].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Quan Liu Research Topics

Disease

69Neoplasms (Cancer)
06/2022 - 08/2007
27Inflammation (Inflammations)
01/2022 - 11/2008
25Infections
10/2022 - 05/2009
19Fibrosis (Cirrhosis)
02/2022 - 07/2006
17Type 2 Diabetes Mellitus (MODY)
11/2021 - 02/2008
16Insulin Resistance
06/2021 - 05/2005
11Hyperglycemia
08/2022 - 08/2013
11Body Weight (Weight, Body)
01/2020 - 02/2008
11Myopia
01/2020 - 10/2006
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2021 - 01/2008
9Kidney Calculi (Kidney Stone)
01/2022 - 06/2017
9Diabetic Cardiomyopathies
01/2019 - 01/2014
9Alzheimer Disease (Alzheimer's Disease)
02/2007 - 01/2002
8Necrosis
12/2021 - 05/2013
8Obesity
01/2019 - 05/2005
8Toxoplasmosis
10/2016 - 05/2011
7Nasopharyngeal Carcinoma
06/2022 - 08/2007
7Hypoxia (Hypoxemia)
02/2022 - 01/2012
7Glioma (Gliomas)
01/2022 - 10/2014
7Glucose Intolerance
11/2021 - 02/2013
7Lung Neoplasms (Lung Cancer)
11/2020 - 06/2008
6Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 02/2008
6Ischemia
12/2021 - 01/2016
6Dyslipidemias (Dyslipidemia)
04/2021 - 07/2006
5Breast Neoplasms (Breast Cancer)
04/2022 - 11/2013
5Cardiomyopathies (Cardiomyopathy)
01/2022 - 01/2017
5Cardiomegaly (Heart Hypertrophy)
01/2022 - 09/2016
4Hypertension (High Blood Pressure)
05/2022 - 01/2014
4Heart Failure
01/2022 - 01/2014
4Neoplasm Metastasis (Metastasis)
01/2022 - 12/2015
4COVID-19
01/2022 - 11/2020
4Esophageal Squamous Cell Carcinoma
01/2021 - 03/2011
4Nephrolithiasis
09/2020 - 01/2018
4Astigmatism
09/2020 - 04/2015
4Hypertrophy
03/2017 - 01/2014
3Coronary Artery Disease (Coronary Atherosclerosis)
04/2022 - 01/2014
3Pulmonary Arterial Hypertension
02/2022 - 01/2021
3Vascular Remodeling
02/2022 - 01/2021
3Brain Neoplasms (Brain Tumor)
01/2022 - 01/2020
3Reperfusion Injury
12/2021 - 05/2019
3Diabetic Nephropathies (Diabetic Nephropathy)
08/2021 - 08/2013

Drug/Important Bio-Agent (IBA)

38Proteins (Proteins, Gene)FDA Link
10/2022 - 01/2002
30Glucose (Dextrose)FDA LinkGeneric
01/2022 - 07/2006
12Pharmaceutical PreparationsIBA
01/2022 - 06/2008
12Insulin (Novolin)FDA Link
01/2022 - 05/2005
12EnzymesIBA
08/2021 - 03/2003
11VaccinesIBA
01/2022 - 08/2008
11Messenger RNA (mRNA)IBA
01/2022 - 11/2009
11MicroRNAs (MicroRNA)IBA
12/2021 - 06/2010
10Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2009
10AntigensIBA
10/2020 - 06/2009
8Biological ProductsIBA
10/2022 - 10/2014
8CytokinesIBA
08/2022 - 05/2013
8Blood Glucose (Blood Sugar)IBA
11/2021 - 01/2014
7Calcium OxalateIBA
01/2022 - 11/2017
7Phosphotransferases (Kinase)IBA
01/2022 - 06/2014
7Streptozocin (Streptozotocin)FDA Link
04/2021 - 05/2005
7Interleukin-33IBA
10/2020 - 05/2013
6p38 Mitogen-Activated Protein KinasesIBA
01/2022 - 06/2016
6ImmunosorbentsIBA
08/2021 - 07/2014
6Sodium Glutamate (Accent)IBA
11/2020 - 07/2006
6AntioxidantsIBA
09/2020 - 02/2007
6AntibodiesIBA
09/2019 - 03/2005
6Triglycerides (Triacylglycerol)IBA
06/2019 - 02/2008
6ZincIBA
01/2019 - 01/2013
6LipidsIBA
11/2018 - 07/2006
5RNA (Ribonucleic Acid)IBA
10/2021 - 06/2005
5Metformin (Glucophage)FDA LinkGeneric
06/2021 - 01/2014
5CholesterolIBA
01/2021 - 02/2008
5DNA (Deoxyribonucleic Acid)IBA
01/2020 - 05/2009
5MetallothioneinIBA
01/2019 - 06/2014
4Long Noncoding RNAIBA
06/2022 - 10/2021
4Tyrosine Kinase InhibitorsIBA
05/2022 - 12/2020
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 06/2017
4InflammasomesIBA
01/2022 - 11/2016
4AlbuminsIBA
09/2021 - 01/2020
4Hypoglycemic Agents (Hypoglycemics)IBA
01/2021 - 12/2012
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2020 - 01/2014
4Small Interfering RNA (siRNA)IBA
01/2020 - 01/2015
4Atorvastatin (Lipitor)FDA Link
01/2020 - 04/2011
4sulforaphaneIBA
01/2019 - 01/2014
4AlginatesIBA
01/2017 - 03/2009
3InterferonsIBA
10/2022 - 01/2020
3Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
05/2022 - 06/2009
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022 - 01/2014
3Histone Deacetylases (Histone Deacetylase)IBA
01/2022 - 10/2014
3CollagenIBA
11/2021 - 01/2017
3osimertinibIBA
11/2021 - 01/2020
3ErbB Receptors (EGF Receptor)IBA
11/2021 - 01/2020
3Indicators and Reagents (Reagents)IBA
09/2021 - 11/2005

Therapy/Procedure

31Therapeutics
05/2022 - 02/2008
10Drug Therapy (Chemotherapy)
05/2022 - 03/2009
9Radiotherapy
06/2022 - 08/2013
8Lasers (Laser)
01/2020 - 03/2010
6Immunotherapy
01/2021 - 06/2009
5Laser In Situ Keratomileusis (LASIK)
01/2020 - 04/2005
4Aftercare (After-Treatment)
04/2022 - 03/2018
4Photothermal Therapy
12/2020 - 03/2015
4Injections
01/2018 - 10/2006
3Ligation
07/2021 - 01/2016